Patents-Review.com
ClassID:

21141 ⎘

A61K39/38 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies Antigens from snakes

Recent Application in this class:
#1
20250295744
2025-09-25

TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION AND PD-1 AXIS BINDING ANTAGONISTS

 #2
20240398923
2024-12-05

SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES

 #3
20240307518
2024-09-19

SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES

 #4
20230038788
2023-02-09

THERAPEUTIC METHODS AND COMPOSITIONS

 #5
20220313831
2022-10-06

PLATFORM FOR ENHANCED TARGETED CELL DELIVERY

 #6
20210346475
2021-11-11

Immunization with polyvalent venom vaccines

 #7
20210268092
2021-09-02

SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES

 #8
20210179670
2021-06-17

HIV vaccine formulation

 #9
20200093910
2020-03-26

Subunit vaccine delivery platform for robust humoral and cellular immune responses

 #10
20190240343
2019-08-08

Platform for enhanced targeted delivery

 #11
20190202870
2019-07-04

HIV vaccine formulation

 #12
20190192653
2019-06-27

COMPOSITIONS AND METHODS FOR TOLERIZING CELLULAR SYSTEMS

 #13
20180071377
2018-03-15

Subunit vaccine delivery platform for robust humoral and cellular immune responses

 #14
20170362280
2017-12-21

HIV vaccine formulation

 #15
20160317675
2016-11-03

Targeting of innate immune response to tumor site

 #16
20160311926
2016-10-27

Therapeutic methods and compositions

 #17
20160311869
2016-10-27

Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide

 #18
20150056246
2015-02-26

Subunit vaccine delivery platform for robust humoral and cellular immune responses

 #19
20120258115
2012-10-11

Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

 #20
20110123629
2011-05-26

Targeting of innate immune response to tumor site

 #21
20100196459
2010-08-05

THERAPEUTIC FORMULATIONS CONTAINING VENOM OR VENOM ANTI-SERUM EITHER ALONE OR IN COMBINATION FOR THE THERAPEUTIC PROPHYLAXIS AND THERAPY OF NEOPLASMS

 #22
20090285825
2009-11-19

NOVEL SNAKE TOXIN

 #23
20080286371
2008-11-20

Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica

 #24
20080081048
2008-04-03

Production of modified neurotoxins

 #25
20080044431
2008-02-21

THERAPEUTIC FORMULATIONS CONTAINING VENOM OR VENOM ANTI-SERUM EITHER ALONE OR IN COMBINATION FOR THE THERAPEUTIC PROPHYLAXIS AND THERAPY OF NEOPLASMS

 #26
20060171968
2006-08-03

Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine

 #27
15349196
2019-05-28

Vaccine formulations and methods of preparation and use thereof